NeoGenomics, Inc.(NASDAQ : NEO)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Services » Medical Or Nursing Services
|GH||Guardant Health, Inc.||2.80%||112.84||0.0%||$104.49m|
|FLGT||Fulgent Genetics, Inc.||4.29%||70.34||0.6%||$74.15m|
|OSH||Oak Street Health, Inc.||4.51%||55.90||0.0%||$67.20m|
|AGL||Agilon Health, Inc.||2.95%||30.00||0.0%||$44.85m|
|ONEM||1Life Healthcare, Inc.||-0.14%||32.76||0.0%||$38.22m|
|ACHC||Acadia Healthcare Co., Inc.||3.31%||65.62||26.9%||$29.38m|
|LHCG||LHC Group, Inc.||1.39%||188.59||2.9%||$29.37m|
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.